DK273186A - Rensede humane immunoglobulin e bindingsfaktorer samt deres fremstilling og anvendelse - Google Patents

Rensede humane immunoglobulin e bindingsfaktorer samt deres fremstilling og anvendelse Download PDF

Info

Publication number
DK273186A
DK273186A DK273186A DK273186A DK273186A DK 273186 A DK273186 A DK 273186A DK 273186 A DK273186 A DK 273186A DK 273186 A DK273186 A DK 273186A DK 273186 A DK273186 A DK 273186A
Authority
DK
Denmark
Prior art keywords
preparation
human immunoglobulin
purified human
binding factors
binding
Prior art date
Application number
DK273186A
Other languages
Danish (da)
English (en)
Other versions
DK273186D0 (da
Inventor
Guy Delespesse
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27262699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK273186(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB858514732A external-priority patent/GB8514732D0/en
Priority claimed from GB858527765A external-priority patent/GB8527765D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK273186D0 publication Critical patent/DK273186D0/da
Publication of DK273186A publication Critical patent/DK273186A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/862—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgE or IgD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK273186A 1985-06-11 1986-06-10 Rensede humane immunoglobulin e bindingsfaktorer samt deres fremstilling og anvendelse DK273186A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858514732A GB8514732D0 (en) 1985-06-11 1985-06-11 Purified immunoglobulin-related factor
GB858525882A GB8525882D0 (en) 1985-06-11 1985-10-21 Purified immunoglobulin-related factor
GB858527765A GB8527765D0 (en) 1985-06-11 1985-11-11 Purified immunoglobulin-related factor

Publications (2)

Publication Number Publication Date
DK273186D0 DK273186D0 (da) 1986-06-10
DK273186A true DK273186A (da) 1986-12-12

Family

ID=27262699

Family Applications (1)

Application Number Title Priority Date Filing Date
DK273186A DK273186A (da) 1985-06-11 1986-06-10 Rensede humane immunoglobulin e bindingsfaktorer samt deres fremstilling og anvendelse

Country Status (6)

Country Link
US (1) US4946788A (ja)
EP (1) EP0205405B1 (ja)
JP (3) JPH07107079B2 (ja)
DE (1) DE3689734T2 (ja)
DK (1) DK273186A (ja)
IE (1) IE61820B1 (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272255A (en) * 1985-01-26 1993-12-21 Ciba-Geigy Corporation Polypeptide factors from colostrum
GB8502006D0 (en) * 1985-01-26 1985-02-27 Ciba Geigy Ag Polypeptide factors from colostrum
GB8514732D0 (en) * 1985-06-11 1985-07-10 Ciba Geigy Ag Purified immunoglobulin-related factor
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
DE3781217T2 (de) * 1986-07-22 1992-12-17 Ciba Geigy Ag Herstellung von verwandten polypeptiden des bindungsfaktors.
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
EP0617127A1 (en) * 1987-12-31 1994-09-28 Tanox Biosystems, Inc. Antigenic epitopes on B cell-bound IgE Immunoglobulins
GB8910263D0 (en) * 1989-05-04 1989-06-21 Ciba Geigy Ag Monoclonal antibodies specific for an immunoglobulin isotype
GB9010356D0 (en) * 1990-05-09 1990-06-27 Ciba Geigy Ag Maturation of hemopoietic cells
WO1992021240A1 (en) * 1991-06-03 1992-12-10 La Jolla Institute For Allergy And Immunology Suppressor t-cell hybridoma
US5786168A (en) * 1990-06-04 1998-07-28 Kirin Beer Kabushiki Kaisha Method for recombinant production of antigen non-specific glycosylation inhibiting factor (GIF)
US5565338A (en) * 1990-06-04 1996-10-15 La Jolla Institute For Allergy And Immunology Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor
JP3156237B2 (ja) * 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体
US5770396A (en) 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
ATE157455T1 (de) * 1993-12-10 1997-09-15 Genentech Inc Methoden zur diagnose von allergie und prüfung anti-allergischer therapeutika
EP0739214B1 (en) * 1994-01-18 1998-03-18 Genentech, Inc. A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
JP3323508B2 (ja) * 1994-10-25 2002-09-09 グラクソ グループ リミテッド Ｃｄ２３に対する結合物質
US7429646B1 (en) 1995-06-05 2008-09-30 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like 2
US20040197326A1 (en) * 1995-07-27 2004-10-07 Genentech, Inc. Method for treatment of allergic asthma
US6685940B2 (en) 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US6635743B1 (en) 1996-03-22 2003-10-21 Human Genome Sciences, Inc. Apoptosis inducing molecule II and methods of use
US7964190B2 (en) * 1996-03-22 2011-06-21 Human Genome Sciences, Inc. Methods and compositions for decreasing T-cell activity
US5965439A (en) * 1996-11-18 1999-10-12 The Regents Of The University Of California Host defense enhancement
TWI239352B (en) * 1997-07-23 2005-09-11 Takara Bio Inc Gene transfer method with the use of serum-free medium
EP1157118A4 (en) * 1999-03-01 2002-07-17 Insight Strategy & Marketing POLYNUCLEOTID ENCODING A POLYPEPTIDE WITH HEPARANASE ACTIVITY AND ITS EXPRESSION IN GENETICALLY MODIFIED CELLS
ATE483472T1 (de) * 2002-05-30 2010-10-15 Macrogenics Inc Cd16a bindungsproteine und verwendung zur behandlung von immunkrankheiten
WO2004041862A2 (en) 2002-11-08 2004-05-21 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
EP2267032A3 (en) 2002-11-08 2011-11-09 Ablynx N.V. Method of administering therapeutic polypeptides, and polypeptides therefor
FR2895263B1 (fr) * 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
PL3026064T3 (pl) 2011-05-13 2019-05-31 Ganymed Pharmaceuticals Gmbh Przeciwciała do leczenia nowotworu z ekspresją klaudyny 6
JP2019519515A (ja) 2016-05-20 2019-07-11 シーダーズ—シナイ メディカル センター アルツハイマー病およびアルツハイマー病に関係する疾病を処置または予防する方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60255734A (ja) * 1984-05-30 1985-12-17 Nichirei:Kk クラス特異的Ｆｃεレセプタ−に対する単クロ−ン性抗体とそれを産生するハイブリド−マ
JPS6112271A (ja) * 1984-06-28 1986-01-20 Hokuyou Kk 被袋果実の除袋方法及び除袋装置
GB8502006D0 (en) * 1985-01-26 1985-02-27 Ciba Geigy Ag Polypeptide factors from colostrum
WO1986006407A1 (en) * 1985-04-23 1986-11-06 Medical Biology Institute IDENTIFICATION OF AN IgE-BINDING PROTEIN BY MOLECULAR CLONING
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications

Also Published As

Publication number Publication date
EP0205405A2 (en) 1986-12-17
JPH08110338A (ja) 1996-04-30
DK273186D0 (da) 1986-06-10
JPH07107079B2 (ja) 1995-11-15
DE3689734D1 (de) 1994-04-28
JPS61289100A (ja) 1986-12-19
US4946788A (en) 1990-08-07
EP0205405B1 (en) 1994-03-23
JP2764019B2 (ja) 1998-06-11
EP0205405A3 (en) 1988-03-16
IE61820B1 (en) 1994-11-30
IE861543L (en) 1986-12-11
JPH1099074A (ja) 1998-04-21
DE3689734T2 (de) 1994-07-21
JP2852918B2 (ja) 1999-02-03

Similar Documents

Publication Publication Date Title
DK273186D0 (da) Rensede humane immunoglobulin e bindingsfaktorer samt deres fremstilling og anvendelse
DK289886A (da) Substituerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK543386D0 (da) Thienooxazinoner deres fremstilling og anvendelse
DK129386A (da) Iodpropargylethere, deres fremstilling og anvendelse
DK29686A (da) 13beta-alkyl-milbemycinderivater samt deres fremstilling og anvendelse
DK420785A (da) 13-halogen- eller 13-hydroxymilbemyciner samt deres fremstilling og anvendelse
DK519586D0 (da) 1-aryl-4-nitro-pyrazoler, deres fremstilling og anvendelse
DK380286D0 (da) Sulfonamider, deres fremstilling og anvendelse
DK467087D0 (da) Lymphocytaktiverende polypeptider og deres anvendelse
DK172486D0 (da) Heterocyclyl-penem-forbindelser samt deres fremstilling og anvendelse
DK393285A (da) Substituerede carbonylphenylsulfonylguanidiner samt deres fremstilling og anvendelse
DK396886A (da) Gem-dihalogen-1,8-diamino-4-azaoctaner, deres fremstilling og anvendelse
DK482786A (da) Herbicide midler og deres anvendelse
DK377786A (da) 1-aryl-5-hydrazino-pyrazoler, deres fremstilling og anvendelse
DK206686A (da) Acylaminomethyl-penem-forbindelser samt deres fremstilling og anvendelse
DK181485A (da) 3-substituerede thiopyroner samt deres fremstilling og anvendelse
DK77286D0 (da) 1-0-acylerede hexosederivater samt deres fremstilling og anvendelse
DK437986D0 (da) 1-amino-3-phenyl-propan-2-ol-derivater samt deres fremstilling og anvendelse
DK361185D0 (da) 2-aminoalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK393986D0 (da) Lactamamider, deres fremstilling og anvendelse
DK471185D0 (da) 4-acylresorcinolethere samt deres fremstilling og anvendelse
DK482385A (da) Fluorerede resorcinolethere samt deres fremstilling og anvendelse
DK13588D0 (da) Heterocyclylalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK451486A (da) Alkenylazoler, deres fremstilling og anvendelse
DK169484A (da) Beta-oxo-alfa-carbamoyl-pyrrolpropionitriler samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment